How much revenue did Indivior generate this year?
Indivior has achieved a revenue of 1.23 B USD this year.
Indivior Revenue 2024
Indivior Revenue
1.23 B USD
Ticker
INDV.L
ISIN
GB00BRS65X63
WKN
A12FHW
In 2024, Indivior's sales reached 1.23 B USD, a 12.44% difference from the 1.09 B USD sales recorded in the previous year.
The Indivior Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2028e | 1.87 | 49,09 |
| 2027e | 1.72 | 53,19 |
| 2026e | 1.42 | 64,55 |
| 2025e | 1.28 | 71,34 |
| 2024e | 1.23 | 74,53 |
| 2023 | 1.09 | 83,81 |
| 2022 | 0.9 | 83,13 |
| 2021 | 0.79 | 83,94 |
| 2020 | 0.65 | 85,78 |
| 2019 | 0.79 | 82,17 |
| 2018 | 1.01 | 87,26 |
| 2017 | 1.09 | 90,48 |
| 2016 | 1.06 | 89,89 |
| 2015 | 1.01 | 90,43 |
| 2014 | 1.12 | 91,48 |
| 2013 | 1.22 | 91,45 |
| 2012 | 1.34 | 92,98 |
| 2011 | 1.25 | 93,54 |
Indivior Revenue, EBIT, Net Income GB00BRS65X63 · A12FHW
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Indivior, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Indivior from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Indivior’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Indivior. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Indivior’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Indivior’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Indivior’s growth potential.
Indivior Revenue, EBIT and net profit per share
| Date | Indivior Revenue | Indivior EBIT | Indivior Net Income |
|---|---|---|---|
| 2028e | 1.87 B undefined | 715.08 M undefined | 605.85 M undefined |
| 2027e | 1.72 B undefined | 621.66 M undefined | 515.25 M undefined |
| 2026e | 1.42 B undefined | 434.48 M undefined | 368.04 M undefined |
| 2025e | 1.28 B undefined | 358.73 M undefined | 294.88 M undefined |
| 2024e | 1.23 B undefined | 286.52 M undefined | 252.45 M undefined |
| 2023 | 1.09 B undefined | 270 M undefined | 2 M undefined |
| 2022 | 901 M undefined | 223 M undefined | -53 M undefined |
| 2021 | 791 M undefined | 206 M undefined | 205 M undefined |
| 2020 | 647 M undefined | 88 M undefined | -148 M undefined |
| 2019 | 785 M undefined | 202 M undefined | 134 M undefined |
| 2018 | 1.01 B undefined | 332 M undefined | 275 M undefined |
| 2017 | 1.09 B undefined | 193 M undefined | 58 M undefined |
| 2016 | 1.06 B undefined | 149 M undefined | 35 M undefined |
| 2015 | 1.01 B undefined | 346 M undefined | 228 M undefined |
| 2014 | 1.12 B undefined | 562 M undefined | 403 M undefined |
| 2013 | 1.22 B undefined | 695 M undefined | 489 M undefined |
| 2012 | 1.34 B undefined | 884 M undefined | 607 M undefined |
| 2011 | 1.25 B undefined | 872 M undefined | 614 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2011 | 1.25 B USD | 872 M USD | 614 M USD |
| 2012 | 1.34 B USD | 884 M USD | 607 M USD |
| 2013 | 1.22 B USD | 695 M USD | 489 M USD |
| 2014 | 1.12 B USD | 562 M USD | 403 M USD |
| 2015 | 1.01 B USD | 346 M USD | 228 M USD |
| 2016 | 1.06 B USD | 149 M USD | 35 M USD |
| 2017 | 1.09 B USD | 193 M USD | 58 M USD |
| 2018 | 1.01 B USD | 332 M USD | 275 M USD |
| 2019 | 785 M USD | 202 M USD | 134 M USD |
| 2020 | 647 M USD | 88 M USD | -148 M USD |
| 2021 | 791 M USD | 206 M USD | 205 M USD |
| 2022 | 901 M USD | 223 M USD | -53 M USD |
| 2023 | 1.09 B USD | 270 M USD | 2 M USD |
| 2024e | 1.23 B USD | 286.52 M USD | 252.45 M USD |
| 2025e | 1.28 B USD | 358.73 M USD | 294.88 M USD |
| 2026e | 1.42 B USD | 434.48 M USD | 368.04 M USD |
| 2027e | 1.72 B USD | 621.66 M USD | 515.25 M USD |
| 2028e | 1.87 B USD | 715.08 M USD | 605.85 M USD |
Indivior stock margins GB00BRS65X63 · A12FHW
The Indivior margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Indivior. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Indivior.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Indivior's sales revenue. A higher gross margin percentage indicates that the Indivior retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Indivior's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Indivior's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Indivior's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Indivior. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Indivior's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Indivior Margin History
| Indivior Gross margin | Indivior Profit margin | Indivior EBIT margin | Indivior Profit margin |
|---|---|---|---|
| 2028e | 83.81 % | 38.32 % | 32.47 % |
| 2027e | 83.81 % | 36.1 % | 29.92 % |
| 2026e | 83.81 % | 30.62 % | 25.94 % |
| 2025e | 83.81 % | 27.94 % | 22.97 % |
| 2024e | 83.81 % | 23.31 % | 20.54 % |
| 2023 | 83.81 % | 24.7 % | 0.18 % |
| 2022 | 83.13 % | 24.75 % | -5.88 % |
| 2021 | 83.94 % | 26.04 % | 25.92 % |
| 2020 | 85.78 % | 13.6 % | -22.87 % |
| 2019 | 82.17 % | 25.73 % | 17.07 % |
| 2018 | 87.26 % | 33.03 % | 27.36 % |
| 2017 | 90.48 % | 17.66 % | 5.31 % |
| 2016 | 89.89 % | 14.08 % | 3.31 % |
| 2015 | 90.43 % | 34.12 % | 22.49 % |
| 2014 | 91.48 % | 50.4 % | 36.14 % |
| 2013 | 91.45 % | 57.15 % | 40.21 % |
| 2012 | 92.98 % | 66.02 % | 45.33 % |
| 2011 | 93.54 % | 69.54 % | 48.96 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2011 | 93.54 % | 69.54 % | 48.96 % |
| 2012 | 92.98 % | 66.02 % | 45.33 % |
| 2013 | 91.45 % | 57.15 % | 40.21 % |
| 2014 | 91.48 % | 50.4 % | 36.14 % |
| 2015 | 90.43 % | 34.12 % | 22.49 % |
| 2016 | 89.89 % | 14.08 % | 3.31 % |
| 2017 | 90.48 % | 17.66 % | 5.31 % |
| 2018 | 87.26 % | 33.03 % | 27.36 % |
| 2019 | 82.17 % | 25.73 % | 17.07 % |
| 2020 | 85.78 % | 13.6 % | -22.87 % |
| 2021 | 83.94 % | 26.04 % | 25.92 % |
| 2022 | 83.13 % | 24.75 % | -5.88 % |
| 2023 | 83.81 % | 24.7 % | 0.18 % |
| 2024e | 83.81 % | 23.31 % | 20.54 % |
| 2025e | 83.81 % | 27.94 % | 22.97 % |
| 2026e | 83.81 % | 30.62 % | 25.94 % |
| 2027e | 83.81 % | 36.1 % | 29.92 % |
| 2028e | 83.81 % | 38.32 % | 32.47 % |
Indivior Aktienanalyse
What does Indivior do?
Indivior PLC is a globally operating company that specializes in the development and marketing of therapies for the treatment of addiction disorders. The company is headquartered in Slough, UK, and employs around 900 people worldwide. Indivior's history dates back to the founding of Reckitt Benckiser Pharmaceuticals in 1994. However, in 2014, the company decided to spin off its pharmaceutical division and continue as an independent company. Since then, Indivior has continuously invested in research and development to develop new and innovative therapies for the treatment of opioid addiction and other addiction disorders. Indivior's business model is based on ensuring comprehensive patient care for those suffering from addiction disorders through close collaboration with health authorities, doctors, and other healthcare professionals. The company relies on a combination of medical therapies and psychosocial support. Indivior operates in various divisions that focus on different aspects of addiction treatment. The key divisions are: - Opioid addiction: Indivior offers various therapies for the treatment of opioid addiction, including Suboxone Film and Sublocade, both based on buprenorphine. - Alcohol addiction: Indivior has also developed a therapy for the treatment of alcohol addiction marketed under the name ALO-02. - Pain therapy: Indivior has also developed a range of pain therapies based on buprenorphine or naloxone. - Research and development: A major focus of Indivior is on researching and developing new therapies for the treatment of addiction disorders. Indivior has also formed partnerships with other companies and organizations in the healthcare industry to improve the care of patients with addiction disorders. This includes collaboration with patient organizations advocating for the interests of patients with addiction disorders. Overall, Indivior has achieved impressive success in developing innovative therapies for the treatment of addiction disorders in recent years. The company has not only strengthened its position as a leading provider of opioid therapies, but also made progress in other areas such as alcohol addiction and pain therapy. However, Indivior has also faced challenges. For example, the company had to address allegations related to the marketing of Suboxone Film and other products. However, Indivior has taken steps to improve its compliance procedures and ensure that its products are marketed in accordance with applicable regulations. Overall, Indivior remains a leading provider of therapies for the treatment of addiction disorders and is committed to improving the quality of life for patients with addiction problems. Indivior ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Indivior's Sales Figures
The sales figures of Indivior originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Indivior’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Indivior's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Indivior’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Indivior stock
How much was the turnover of the company Indivior compared to the previous year?
The revenue of Indivior has increased by 12.44% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Indivior?
The revenue of Indivior is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Indivior measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Indivior so important for investors?
The revenue of Indivior is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Indivior pay?
Over the past 12 months, Indivior paid a dividend of 0.07 USD . This corresponds to a dividend yield of about 0.55 %. For the coming 12 months, Indivior is expected to pay a dividend of 0 USD.
What is the dividend yield of Indivior?
The current dividend yield of Indivior is 0.55 %.
When does Indivior pay dividends?
Indivior pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Indivior?
Indivior paid dividends every year for the past 5 years.
What is the dividend of Indivior?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Indivior located?
Indivior is assigned to the 'Health' sector.
Wann musste ich die Aktien von Indivior kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Indivior from 7/29/2016 amounting to 0.073 USD, you needed to have the stock in your portfolio before the ex-date on 6/16/2016.
When did Indivior pay the last dividend?
The last dividend was paid out on 7/29/2016.
What was the dividend of Indivior in the year 2023?
In the year 2023, Indivior distributed 0 USD as dividends.
In which currency does Indivior pay out the dividend?
The dividends of Indivior are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Indivior stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Indivior
Our stock analysis for Indivior Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Indivior Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
